{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:27:18Z","timestamp":1794738438927,"version":"4.9.1"},"reference-count":140,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Sepsis constitutes a profoundly heterogeneous and dynamic clinical syndrome, precipitated by a maladaptive host response to infection in which the immune system\u2019s regulatory balance is fundamentally disrupted. The intricate interplay between proinflammatory and anti-inflammatory pathways, ordinarily responsible for maintaining immune homeostasis, becomes pathologically skewed. Within this altered immunological landscape, cytokines serve as pivotal mediators, orchestrating a cascade of cellular events that may culminate in a rapid transition from systemic hyperinflammation to a state of immune exhaustion or suppression. This review offers a critical synthesis of the current scientific literature on the immunopathogenesis of sepsis, with a particular emphasis on the molecular and cellular mechanisms governing cytokine regulation. Special attention is directed toward elucidating the contribution of these mediators to the onset and progression of multiorgan dysfunction syndrome (MODS), a central and often fatal complication of severe sepsis. Through an integrative examination of the principal immune signaling networks and pathophysiological processes involved in sepsis, this review provides a cohesive theoretical framework positioning immune dysregulation as the fundamental axis of clinical deterioration. Such an approach underscores the imperative for a deeper insight into the immunological architecture of sepsis, thereby laying the groundwork for the rational design of targeted, mechanism-based therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1682306","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:28:49Z","timestamp":1762324129000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Cytokines in sepsis: a critical review of the literature on systemic inflammation and multiple organ dysfunction"],"prefix":"10.3389","volume":"16","author":[{"given":"Roberta","family":"Vella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Panci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Carini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Malta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Vieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Davide","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Puntarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Zerbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Argo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147770","article-title":"From molecular mechanisms to clinical therapy: understanding sepsis-induced multiple organ dysfunction","volume":"25","author":"Srdi\u0107","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"165974","DOI":"10.1155\/2013\/165974","article-title":"Cytokines in sepsis: potent immunoregulators and potential therapeutic targets\u2013an updated view","volume":"2013","author":"Schulte","year":"2013","journal-title":"Mediators Inflammation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41392-021-00816-9","article-title":"Signaling pathways and intervention therapies in sepsis","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0639-8","article-title":"Cytokine storm and sepsis disease pathogenesis","volume":"39","author":"Chousterman","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911740","article-title":"Cytokine storm-definition, causes, and implications","volume":"23","author":"Jarczak","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-59815-9_30","article-title":"Cytokine storm and sepsis-induced multiple organ dysfunction syndrome","volume":"1448","author":"Carcillo","year":"2024","journal-title":"Adv Exp Med Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2012.09.004","article-title":"The inflammatory response in sepsis","volume":"34","author":"Bosmann","year":"2013","journal-title":"Trends Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002044","article-title":"A review of GM-CSF therapy in sepsis","volume":"94","author":"Mathias","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40779-022-00422-y","article-title":"Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options","volume":"9","author":"Liu","year":"2022","journal-title":"Mil Med Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1170","DOI":"10.1002\/ctm2.1170","article-title":"Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis","volume":"13","author":"Zhang","year":"2023","journal-title":"Clin Transl Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1144229","article-title":"Endothelial dysfunction and immunothrombosis in sepsis","volume":"14","author":"Maneta","year":"2023","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxab393","article-title":"The pathophysiology of sepsis - 2021 update: Part 2, organ dysfunction and assessment","volume":"79","author":"Jacobi","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"B14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13054-024-04964-6","article-title":"Towards personalized medicine: a scoping review of immunotherapy in sepsis","volume":"28","author":"Slim","year":"2024","journal-title":"Crit Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11111581","article-title":"Evolution of the concept of sepsis","volume":"11","author":"Vincent","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.20471\/acc.2022.61.s1.11","article-title":"Sepsis definition: what\u2019s new in the treatment guidelines","volume":"61","author":"Srzi\u0107","year":"2022","journal-title":"Acta Clin Croat"},{"key":"B18","doi-asserted-by":"publisher","first-page":"642462","DOI":"10.1155\/2010\/642462","article-title":"Novel insights for systemic inflammation in sepsis and hemorrhage","volume":"2010","author":"Cai","year":"2010","journal-title":"Mediators Inflammation"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020962","article-title":"PAMPs and DAMPs in sepsis: A review of their molecular features and potential clinical implications","volume":"25","author":"Cicchinelli","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168882","article-title":"Targeting cytokines, pathogen-associated molecular patterns, and damage-associated molecular patterns in sepsis via blood purification","volume":"22","author":"Moriyama","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02536","article-title":"DAMPs and NETs in sepsis","volume":"10","author":"Denning","year":"2019","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1146\/annurev-pathmechdis-012419-032847","article-title":"DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation","volume":"15","author":"Zindel","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/v3060920","article-title":"Pattern recognition receptors and the innate immune response to viral infection","volume":"3","author":"Thompson","year":"2011","journal-title":"Viruses"},{"key":"B26","doi-asserted-by":"publisher","first-page":"107087","DOI":"10.1016\/j.intimp.2020.107087","article-title":"Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets","volume":"89","author":"Kumar","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2741\/1304","article-title":"NF-kappaB action in sepsis: the innate immune system and the heart","volume":"9","author":"Brown","year":"2004","journal-title":"Front Biosci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222313009","article-title":"Pathogenesis and treatment of cytokine storm induced by infectious diseases","volume":"22","author":"Tang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2004.10.006","article-title":"Cytokine: more than a new word, a new concept proposed by Stanley Cohen thirty years ago","volume":"28","author":"Cohen","year":"2004","journal-title":"Cytokine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-immunol-042718-041447","article-title":"Fine-tuning cytokine signals","volume":"37","author":"Lin","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.108","article-title":"2. Cytokines and chemokines","volume":"111","author":"Borish","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54275","article-title":"Navigating the cytokine storm: A comprehensive review of chemokines and cytokines in sepsis","volume":"16","author":"Reddy","year":"2024","journal-title":"Cureus"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004433","article-title":"Cytokines: from clinical significance to quantification","volume":"8","author":"Liu","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00856-y","article-title":"Targeting IL-6 trans-signalling: past, present and future prospects","volume":"23","author":"Rose-John","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318211ff56","article-title":"Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model","volume":"39","author":"Barkhausen","year":"2011","journal-title":"Crit Care Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"103309","DOI":"10.1016\/j.isci.2021.103309","article-title":"A single aromatic residue in sgp130Fc\/olamkicept allows the discrimination between interleukin-6 and interleukin-11 trans-signaling","volume":"24","author":"Lokau","year":"2021","journal-title":"iScience"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.649509","article-title":"Shedding of endogenous interleukin-6 receptor (IL-6R) is governed by A disintegrin and metalloproteinase (ADAM) proteases while a full-length IL-6R isoform localizes to circulating microvesicles","volume":"290","author":"Schumacher","year":"2015","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001852","article-title":"Pediatric sepsis biomarker risk model-II: redefining the pediatric sepsis biomarker risk model with septic shock phenotype","volume":"44","author":"Wong","year":"2016","journal-title":"Crit Care Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S0898-6568(98)00018-7","article-title":"TNF-related ligands and their receptors","volume":"10","author":"Orlinick","year":"1998","journal-title":"Cell Signal"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1159\/000289201","article-title":"TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells","volume":"11","author":"Chen","year":"2010","journal-title":"Curr Dir Autoimmun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","article-title":"TNF alpha and the TNF receptor superfamily: structure-function relationship(s)","volume":"50","author":"Idriss","year":"2000","journal-title":"Microsc Res Tech"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119647","article-title":"Pro- and anti-inflammatory prostaglandins and cytokines in humans: A mini review","volume":"24","author":"Wautier","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2741\/3561","article-title":"Sepsis as a model of SIRS","volume":"14","author":"Bhatia","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3182982add","article-title":"Antitumor necrosis factor therapy is associated with improved survival in clinical sepsis trials: a meta-analysis","volume":"41","author":"Qiu","year":"2013","journal-title":"Crit Care Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17552-1","article-title":"Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies","volume":"364","author":"Dorman","year":"2004","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"113683","DOI":"10.1016\/j.biopha.2022.113683","article-title":"Role of interferon-gamma (IFN-\u03b3) and IFN-\u03b3 receptor 1\/2 (IFN\u03b3R1\/2) in regulation of immunity, infection, and cancer development: IFN-\u03b3-dependent or independent pathway","volume":"155","author":"Ding","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: An overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102088","article-title":"Chemokines from a structural perspective","volume":"18","author":"Miller","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"9603271221078871","DOI":"10.1177\/09603271221078871","article-title":"Inflammatory mediators of cytokines and chemokines in sepsis: From bench to bedside","volume":"41","author":"Doganyigit","year":"2022","journal-title":"Hum Exp Toxicol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"R58","DOI":"10.1186\/cc10031","article-title":"Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis","volume":"15","author":"Bo","year":"2011","journal-title":"Crit Care"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01015","article-title":"Is there a role for hematopoietic growth factors during sepsis","volume":"9","author":"Chousterman","year":"2018","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.622601","article-title":"Potential targets to mitigate trauma- or sepsis-induced immune suppression","volume":"12","author":"Bergmann","year":"2021","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021873","article-title":"TGF-\u03b2 and the TGF-\u03b2 Family: context-dependent roles in cell and tissue physiology","volume":"8","author":"Morikawa","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13613-023-01109-w","article-title":"Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial","volume":"13","author":"Daix","year":"2023","journal-title":"Ann Intensive Care"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhv292","article-title":"YAP is a critical inducer of SOCS3, preventing reactive astrogliosis","volume":"26","author":"Huang","year":"2016","journal-title":"Cereb Cortex"},{"key":"B63","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12879-019-3800-2","article-title":"Is Interleukin-6 a better predictor of successful antibiotic therapy than procalcitonin and C-reactive protein? A single center study in critically ill adults","volume":"19","author":"Weidhase","year":"2019","journal-title":"BMC Infect Dis"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S384351","article-title":"Diagnostic and prognostic value of interleukin-6 in emergency department sepsis patients","volume":"15","author":"Yu","year":"2022","journal-title":"Infect Drug Resist"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.1.5.9497","article-title":"Tocilizumab","volume":"1","author":"Venkiteshwaran","year":"2009","journal-title":"MAbs"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001639","article-title":"Effects of tocilizumab on experimental severe acute pancreatitis and associated acute lung injury","volume":"44","author":"Chen","year":"2016","journal-title":"Crit Care Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-021-00488-6","article-title":"Systematic review and subgroup meta-analysis of randomized trials to determine Tocilizumab\u2019s place in COVID-19 pneumonia","volume":"10","author":"Klopfenstein","year":"2021","journal-title":"Infect Dis Ther"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"100817","DOI":"10.1016\/j.xcrm.2022.100817","article-title":"Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial","volume":"3","author":"Leventogiannis","year":"2022","journal-title":"Cell Rep Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"98791","DOI":"10.5492\/wjccm.v14.i2.98791","article-title":"Why should lymphocytes immune profile matter in sepsis","volume":"14","author":"Nedel","year":"2025","journal-title":"World J Crit Care Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.07.004","article-title":"NF-\u03baB: blending metabolism, immunity, and inflammation","volume":"43","author":"Capece","year":"2022","journal-title":"Trends Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2011.13","article-title":"NF-\u03baB in immunobiology","volume":"21","author":"Hayden","year":"2011","journal-title":"Cell Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03baB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol Cancer"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.716469","article-title":"NF-\u03baB: at the borders of autoimmunity and inflammation","volume":"12","author":"Barnabei","year":"2021","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajpath.2013.09.007","article-title":"New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease","volume":"184","author":"De Nardo","year":"2014","journal-title":"Am J Pathol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"115497","DOI":"10.1016\/j.biopha.2023.115497","article-title":"NLRP3 inflammasome involves in the pathophysiology of sepsis-induced myocardial dysfunction by multiple mechanisms","volume":"167","author":"Zhang","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of NLRP3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.571810","article-title":"Reactive oxygen species interact with NLRP3 inflammasomes and are involved in the inflammation of sepsis: from mechanism to treatment of progression","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Physiol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"101781","DOI":"10.1016\/j.smim.2023.101781","article-title":"Pyroptosis-induced inflammation and tissue damage","volume":"69","author":"Vasudevan","year":"2023","journal-title":"Semin Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13789","article-title":"First-in-human safety, tolerability, and pharmacokinetic results of DFV890, an oral low-molecular-weight NLRP3 inhibitor","volume":"17","author":"Gatlik","year":"2024","journal-title":"Clin Transl Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14060645","article-title":"Effects of NF-\u03baB inhibitor on sepsis depend on the severity and phase of the animal sepsis model","volume":"14","author":"Park","year":"2024","journal-title":"J Pers Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R116.760884","article-title":"Long non-coding RNAs (lncRNAs) and their transcriptional control of inflammatory responses","volume":"292","author":"Mathy","year":"2017","journal-title":"J Biol Chem"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00718","article-title":"Long non-coding RNAs in the regulation of the immune response and trained immunity","volume":"11","author":"Flores-Concha","year":"2020","journal-title":"Front Genet"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA","volume":"141","author":"Lu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.798713","article-title":"Regulatory role of non-coding RNAs on immune responses during sepsis","volume":"12","author":"Ghafouri-Fard","year":"2021","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40560-020-00497-6","article-title":"Accuracy of circulating microRNAs in diagnosis of sepsis: a systematic review and meta-analysis","volume":"8","author":"Shen","year":"2020","journal-title":"J Intensive Care"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12092049","article-title":"MicroRNAs in sepsis","volume":"12","author":"Valsamaki","year":"2024","journal-title":"Biomedicines"},{"key":"B90","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41420-024-02002-6","article-title":"Roles of long noncoding RNAs in human inflammatory diseases","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov"},{"key":"B91","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12967-024-06032-7","article-title":"LIN28A-dependent lncRNA NEAT1 aggravates sepsis-induced acute respiratory distress syndrome through destabilizing ACE2 mRNA by RNA methylation","volume":"23","author":"Liu","year":"2025","journal-title":"J Transl Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","article-title":"Exosomes","volume":"88","author":"Pegtel","year":"2019","journal-title":"Annu Rev Biochem"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B94","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40779-024-00527-6","article-title":"Exosomal mediators in sepsis and inflammatory organ injury: unraveling the role of exosomes in intercellular crosstalk and organ dysfunction","volume":"11","author":"Gong","year":"2024","journal-title":"Mil Med Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02140","article-title":"Exosomes in sepsis","volume":"11","author":"Murao","year":"2020","journal-title":"Front Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-079152","article-title":"Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo","volume":"110","author":"Bhatnagar","year":"2007","journal-title":"Blood"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1186\/s12967-024-05817-0","article-title":"Exosomes as novel biomarkers in sepsis and sepsis related organ failure","volume":"22","author":"Yuan","year":"2024","journal-title":"J Transl Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13054-025-05320-y","article-title":"Study on the diagnostic role of exosome-derived miRNAs in postoperative septic shock and non-septic shock patients","volume":"29","author":"Garc\u00eda-Concejo","year":"2025","journal-title":"Crit Care"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.944864","article-title":"Analysis of exosome-derived microRNAs as early biomarkers of lipopolysaccharide-induced acute kidney injury in rats","volume":"13","author":"Da-Silva","year":"2022","journal-title":"Front Physiol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1136964","article-title":"Mesenchymal stem cell-derived exosomes for treatment of sepsis","volume":"14","author":"Homma","year":"2023","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13054-025-05283-0","article-title":"The NET effect\u201d: Neutrophil extracellular traps\u2014a potential key component of the dysregulated host immune response in sepsis","volume":"29","author":"Retter","year":"2025","journal-title":"Crit Care"},{"key":"B102","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41420-023-01614-8","article-title":"Neutrophil extracellular traps contribute to immunothrombosis formation via the STING pathway in sepsis-associated lung injury","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell Death Discov"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00081","article-title":"Neutrophil extracellular traps and its implications in inflammation: an overview","volume":"8","author":"Delgado-Rizo","year":"2017","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-457671","article-title":"NETosis: how vital is it","volume":"122","author":"Yipp","year":"2013","journal-title":"Blood"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e2812","DOI":"10.1038\/cddis.2017.52","article-title":"The role of extracellular histone in organ injury","volume":"8","author":"Silk","year":"2017","journal-title":"Cell Death Dis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"407324","DOI":"10.1155\/2012\/407324","article-title":"The role of complement system in septic shock","author":"Charchaflieh","year":"2012","journal-title":"Clin Dev Immunol 2012"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00893.x","article-title":"Sepsis, complement and the dysregulated inflammatory response","volume":"13","author":"Ward","year":"2009","journal-title":"J Cell Mol Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.907992","article-title":"Endothelial activation and microcirculatory disorders in sepsis","volume":"9","author":"Raia","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.3.2018","article-title":"Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation","volume":"166","author":"Faure","year":"2001","journal-title":"J Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.729251","article-title":"COVID-19 vaccine-related thrombosis: A systematic review and exploratory analysis","volume":"12","author":"Bilotta","year":"2021","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4161\/viru.26907","article-title":"The role of mitochondrial dysfunction in sepsis-induced multi-organ failure","volume":"5","author":"Singer","year":"2014","journal-title":"Virulence"},{"key":"B112","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ccc.2017.08.003","article-title":"Mechanisms of organ dysfunction in sepsis","volume":"34","author":"Pool","year":"2018","journal-title":"Crit Care Clin"},{"key":"B113","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13613-024-01377-0","article-title":"Organ crosstalk and dysfunction in sepsis","volume":"14","author":"Borges","year":"2024","journal-title":"Ann Intensive Care"},{"key":"B114","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4266\/acc.2020.00248","article-title":"Sepsis-induced cardiac dysfunction: a review of pathophysiology","volume":"35","author":"Habimana","year":"2020","journal-title":"Acute Crit Care"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2023.13114","article-title":"Sepsis\u2212induced cardiac dysfunction and pathogenetic mechanisms (Review)","volume":"28","author":"Song","year":"2023","journal-title":"Mol Med Rep"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S327661","article-title":"The main causes and mechanisms of increase in cardiac troponin concentrations other than acute myocardial infarction (Part 1): physical exertion, inflammatory heart disease, pulmonary embolism, renal failure, sepsis","volume":"17","author":"Chauin","year":"2021","journal-title":"Vasc Health Risk Manag"},{"key":"B117","article-title":"Organ dysfunction in sepsis: an ominous trajectory from infection to death","volume":"92","author":"Caraballo","year":"2019","journal-title":"Yale J Biol Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"k4891","DOI":"10.1136\/bmj.k4891","article-title":"Sepsis associated acute kidney injury","volume":"364","author":"Poston","year":"2019","journal-title":"BMJ"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-022-10218-w","article-title":"Cardiorenal syndrome: long road between kidney and heart","volume":"27","author":"Junho","year":"2022","journal-title":"Heart Fail Rev"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030964","article-title":"Acute kidney injury during sepsis and prognostic role of coexistent chronic heart failure","volume":"14","author":"Soukup","year":"2025","journal-title":"J Clin Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-023-09972-9","article-title":"Toll-like receptor 4 promotes the inflammatory response in septic acute kidney injury by promoting p38 mitogen-activated protein kinase phosphorylation","volume":"55","author":"Yue","year":"2023","journal-title":"J Bioenerg Biomembr"},{"key":"B122","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12964-024-01620-y","article-title":"Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications","volume":"22","author":"Qiao","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1277161","article-title":"Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"762320","DOI":"10.1155\/2014\/762320","article-title":"Sepsis associated encephalopathy","author":"Chaudhry","year":"2014","journal-title":"Adv Med 2014"},{"key":"B125","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s13054-023-04655-8","article-title":"The spectrum of sepsis-associated encephalopathy: a clinical perspective","volume":"27","author":"Sonneville","year":"2023","journal-title":"Crit Care"},{"key":"B126","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2110-5820-3-15","article-title":"Understanding brain dysfunction in sepsis","volume":"3","author":"Sonneville","year":"2013","journal-title":"Ann Intensive Care"},{"key":"B127","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/08830185.2014.889129","article-title":"The role of the liver in sepsis","volume":"33","author":"Yan","year":"2014","journal-title":"Int Rev Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/68363","article-title":"Liver dysfunction in sepsis","volume":"27","author":"Wo\u017anica","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"B129","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13054-022-04090-1","article-title":"The gut\u2013liver axis in sepsis: interaction mechanisms and therapeutic potential","volume":"26","author":"Zhang","year":"2022","journal-title":"Crit Care"},{"key":"B130","doi-asserted-by":"publisher","first-page":"99987","DOI":"10.3748\/wjg.v31.i1.99987","article-title":"Gut-liver axis in sepsis-associated liver injury: Epidemiology, challenges and clinical practice","volume":"31","author":"Moura","year":"2025","journal-title":"World J Gastroenterol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202311-2086SO","article-title":"From ICU syndromes to ICU subphenotypes: consensus report and recommendations for developing precision medicine in the ICU","volume":"210","author":"Gordon","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12061355","article-title":"Non-coding RNA networks as potential novel biomarker and therapeutic target for sepsis and sepsis-related multi-organ failure","volume":"12","author":"Di Raimondo","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B133","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s40001-025-02561-z","article-title":"Exosomes and MicroRNAs: key modulators of macrophage polarization in sepsis pathophysiology","volume":"30","author":"Saadh","year":"2025","journal-title":"Eur J Med Res"},{"key":"B134","doi-asserted-by":"publisher","first-page":"108347","DOI":"10.1016\/j.intimp.2021.108347","article-title":"LncRNA-Cox2 regulates macrophage polarization and inflammatory response through the CREB-C\/EBP\u03b2 signaling pathway in septic mice","volume":"101","author":"Wang","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.2478\/jccm-2022-0020","article-title":"Personalized physiological medicine as the future of intensive care medicine","volume":"8","author":"Azamfirei","year":"2022","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi5200","article-title":"The spectrum of inflammatory responses","volume":"374","author":"Medzhitov","year":"2021","journal-title":"Science"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fsci.2024.1469417","article-title":"Deciphering sepsis: transforming diagnosis and treatment through systems immunology","volume":"2","author":"Hancock","year":"2025","journal-title":"Front Sci"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1493214","article-title":"Immunoadjuvant therapy in the regulation of cell death in sepsis: recent advances and future directions","volume":"15","author":"Islam","year":"2024","journal-title":"Front Immunol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00134-024-07735-7","article-title":"Management of adult sepsis in resource-limited settings: global expert consensus statements using a Delphi method","volume":"51","author":"Thwaites","year":"2025","journal-title":"Intensive Care Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s13054-023-04762-6","article-title":"Targeting the host response in sepsis: current approaches and future evidence","volume":"27","author":"Bode","year":"2023","journal-title":"Crit Care"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1682306\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:28:50Z","timestamp":1762324130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1682306\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":140,"alternative-id":["10.3389\/fimmu.2025.1682306"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1682306","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"article-number":"1682306"}}